Biopharmaceutical company
Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease
MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BURRELL INTERNATIONAL GROUP LLC
410 First Street, SE, Suite 300, Washington, DC, 20003, US
DEBORAH LYNN BURRELL